Olfactory Training in Mild Cognitive Impairment
Part of paid clinical trials in New York, New York.
- Sponsor
- Jeffrey Motter
- Study ID
- NCT06825403
- Status
- Recruiting
Conditions
- Mild Cognitive Impairment
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Olfactory Memory Training — BEHAVIORALParticipants will complete 48 OMT sessions at home lasting approximately 10 minutes each over 3 months.
- Visual Memory Training — BEHAVIORALParticipants will complete 48 VMT sessions at home lasting approximately 10 minutes each over 3 months.
Study Details
Sense of smell tends to decline in individuals with early Alzheimer's disease, typically earlier than when other senses and thinking abilities begin to decline. Memory for new odors is particularly diminished in these individuals. Existing treatments for AD do not improve these symptoms. A targeted treatment for improving sense of smell, called 'Olfactory Training', has been used to improve sense of smell in people with various forms of smell loss, though it is not known whether it can improve smell abilities and thinking abilities in patients who are at high risk of developing Alzheimer's disease. The investigators will conduct a randomized clinical trial with patients who have mild cognitive impairment (MCI). This is an early phase of memory loss that is worse than normal aging and may precede Alzheimer's disease. Patients will be randomized to either olfactory memory training or visual memory training for 3 months, with a final follow-up visit at 6 months. This study will attempt to determine if olfactory training is a useful for improving smell abilities, thinking abilities, and everyday functioning by examining change in these outcomes over time.
Key Dates
- Start date
- Aug 7, 2025
- Status verified
- Jul 2025
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Olfactory Memory Training
- Active Comparator: Visual Memory Training
Primary Outcome Measure
Change in Preclinical Alzheimer's Cognitive Composite 5 (PACC5) [ Time Frame: Baseline, 3 Months, 6 Months ]
Central Contacts
- Jeffrey N Motter, PhD6467748654
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New York State Psychiatric Institute | New York | New York | 10032 |
Find similar trials in New York, NY
Related Studies
- Tau PET in Imaging and Cognition: Healthy Adults From 55-90Recruiting · Yaakov Stern · New York, New York
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- The Comparative Effectiveness Dementia & Alzheimer's RegistryEnrolling By Invitation · Weill Medical College of Cornell University · New York, New York
- Autoimmune Features of Neurodegenerative DisordersRecruiting · Columbia University · New York, New York